The Latest Breaking News from Aerie

The apparel industry is thriving, fueled by millennial-driven trends like sustainability, digital-first shopping habits, and increasing discretionary spending. Against this dynamic backdrop, fundamentally robust stocks like Abercrombie & Fitch (ANF), American Eagle Outfitters (AEO), and Revolve Group (RVLV) are not only resonating with this influential demographic but also emerging as…

American Eagle has filed a suit against Amazon after allegedly selling knock-offs of its Aerie products.

The best one-piece swimsuits deliver on design, fabric and fit for a failsafe pool-side look

These are 28 of the most famous plus size models in the world from Ashley Graham to Tess Holliday

Its partnership with intimates label Liberare focuses on accessibility first.

Alcon will buy glaucoma drugs maker Aerie Pharmaceuticals in a $770 million deal that sent the biotech stock flying Tuesday.

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has dosed the first patient in the Phase 3 COMET-2 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).